Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs.
- DOI
- 10.1002/epi.70152
- Published
- 2026 Jun
- Container
- Epilepsia
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/epi.70152,
title = {Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs.},
author = {Auvin S and Arzimanoglou A and French J and Knupp KG and Lagae L and Trinka E and Dlugos D and Perucca E},
year = {2026},
journal = {Epilepsia},
doi = {10.1002/epi.70152},
url = {https://doi.org/10.1002/epi.70152}
}RIS
TY - JOUR TI - Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs. AU - Auvin S AU - Arzimanoglou A AU - French J AU - Knupp KG AU - Lagae L AU - Trinka E AU - Dlugos D AU - Perucca E PY - 2026 JO - Epilepsia DO - 10.1002/epi.70152 UR - https://doi.org/10.1002/epi.70152 ER -
APA
S, A., A, A., J, F., KG, K., L, L., E, T., D, D., & E, P. (2026). Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs.. Epilepsia. https://doi.org/10.1002/epi.70152
Source records
- pubmed · retrieved 2026-09-25T12:57:39.340Z
- europe-pmc · retrieved 2026-09-25T12:57:39.346Z